22 May 2024 - 23 May 2024

France

WorkInHealth Foundation Career Fair | 4th edition

Our Ambassadors

The role of our Ambassadors is to promote our Foundation’s mission, objectives and activities, while enhancing its visibility and credibility.

We have developed Ambassador partnerships with various organisations across the health sector. We chose to join forces with them because the members of these clusters, networks, and initiatives, are directly impacted by the current skills and talent gap. Together with our Ambassadors, we work to support them and provide a solution to their recruitment issues.

AIT For Health

AIT For Health

We aspire to boost new initiatives in companies and to see the emergence of new collaborations around artificial intelligence projects. This initiative is an opportunity to allow various actors of both ecosystems, health and artificial intelligence, to meet up and share their experiences to drive AI innovation forward.

Bioliance

Bioliance

Bioliance is a network of medical biology laboratories on the Nantes metropolis, peripheral cities and a South Loire axis from Nantes to Vendée. Most of our facilities welcome patients called «city» patients for prevention, diagnosis or follow-up analyses.

Cap Digital

Cap Digital

An agitator and facilitator role that brings together all the actors of the digital economy & sustainable development (and more) and makes them work collectively to bring their visions, prototypes, projects, technologies and services to thebeyond everyone’s expectations. To achieve this, we offer our services to support innovation, acceleration, digital transformation and the ecological transition.

CEBR

CEBR

CEBR is a membership-driven network of life science clusters and regional ecosystems across Europe, representing over 40 subscription members and hundreds of cluster partners across the world. Together, we represent and support a critical mass of SMEs, and hundreds of universities and research centres.

Sandoz

Sandoz

At Sandoz, we're the leading global provider of ‘off-patent’ medicines. That means when product patents expire, we swiftly develop matching high-quality medicines, which are more affordable and accessible. Our medicines create competition for the original or ‘reference’ medicines and always match them for quality.